Elevated CSF GAP‐43 is Alzheimer's disease specific and associated with tau and amyloid pathology

Abstract

The presynaptic marker GAP-43 is associated with both diagnosis and neuropathology of AD and thus may be useful as a sensitive and specific biomarker for clinical research.